Morgan Stanley Alvotech Transaction History

Morgan Stanley

$1.59 Trillion
Q3 2025

A detailed history of Morgan Stanley transactions in Alvotech stock. As of the latest transaction made, Morgan Stanley holds 175,071 shares of ALVO stock, worth $961,139. This represents 0.0% of its overall portfolio holdings.

Number of Shares

175,071

Previous 357,295 51.0%

Holding current value

$961,139

Previous $3.26 Million 56.02%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$7.82 - $9.81 $1.42 Million - $1.79 Million	-182,224 Reduced 51.0%	175,071 $1.43 Million
Q2 2025 Aug 15, 2025	SELL	$7.84 - $11.45 $5.14 Million - $7.5 Million	-655,093 Reduced 64.71%	357,295 $3.26 Million
Q1 2025 May 15, 2025	SELL	$9.55 - $13.52 $4.49 Million - $6.35 Million	-469,680 Reduced 31.69%	1,012,388 $9.79 Million
Q4 2024 Feb 14, 2025	SELL	$11.28 - $13.2 $2.9 Million - $3.4 Million	-257,272 Reduced 14.79%	1,482,068 $19.6 Million
Q3 2024 May 14, 2025	BUY	$10.76 - $12.99 $18.1 Million - $21.8 Million	1,681,049 Added 2883.89%	1,739,340 $20.7 Million

Q3 2024 Nov 14, 2024	BUY	$10.76 - $12.99 $18.1 Million - $21.8 Million	1,681,049 Added 2883.89%	1,739,340 $20.7 Million
Q2 2024 May 14, 2025	SELL	$11.4 - $14.51 $16.2 Million - $20.7 Million	-1,423,777 Reduced 96.07%	58,291 $708,000
Q2 2024 Oct 17, 2024	SELL	$11.4 - $14.51 $8.75 Million - $11.1 Million	-767,310 Reduced 92.94%	58,291 $708,000
Q2 2024 Aug 14, 2024	SELL	$11.4 - $14.51 $8.75 Million - $11.1 Million	-767,310 Reduced 92.94%	58,291 $708,000
Q1 2024 Oct 17, 2024	BUY	$11.36 - $17.27 $8.72 Million - $13.3 Million	767,310 Added 1316.34%	825,601 $10.1 Million
Q1 2024 Aug 16, 2024	BUY	$11.36 - $17.27 $9.38 Million - $14.3 Million	825,575 Added 3175288.5%	825,601 $10.1 Million
Q1 2024 May 15, 2024	BUY	$11.36 - $17.27 $9.38 Million - $14.3 Million	825,575 Added 3175288.5%	825,601 $10.1 Million
Q4 2023 Aug 16, 2024	SELL	$8.55 - $11.48 $498,165 - $668,882	-58,265 Reduced 99.96%	26 $0
Q4 2023 Feb 13, 2024	BUY	$8.55 - $11.48 $213 - $287	25 Added 2500.0%	26 $0
Q3 2023 Nov 15, 2023	BUY	$8.12 - $10.07 $8 - $10	1 New	1 $0
Q1 2023 May 15, 2023	SELL	$10.01 - $14.03 $10.4 Million - $14.6 Million	-1,038,727 Reduced 99.89%	1,193 $15,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $9.55 $757,833 - $9.91 Million	1,038,128 Added 57931.25%	1,039,920 $7.03 Million
Q2 2022 Aug 15, 2022	BUY	$8.21 - $11.19 $14,712 - $20,052	1,792 New	1,792 $15,000

Others Institutions Holding ALVO

# of Institutions

Shares Held

15M

Call Options Held

Put Options Held

View Full List

About Alvotech

Ticker ALVO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 248,650,000
Market Cap $1.37B
Description
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...

More about ALVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account